Miranda Jayne Toledano

CIK 1686530 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 11, 2022 · Latest: Jan. 11, 2022

On this page

Insider at

Insider transactions

1 buys (P) 0 sells (S) Net: $19,910 + 23 non-open-market transactions below Avg return of open purchases vs now: 67.4% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

23 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 29, 2025 ENTX P 11,000 $1.81 $19,910 426,575 Direct +2.65% Acquired 67.4% (price as of 2026-08-19)
Dec. 22, 2023 ENTX P 23,952 $0.12 $2,874 23,952 Direct — Acquired 2425.6% (price as of 2026-08-19)
Dec. 22, 2023 ENTX P 23,952 $0.71 $17,006 110,752 Direct +27.59% Acquired 326.9% (price as of 2026-08-19)
April 4, 2023 ENTX P 30,000 $1.01 $30,300 86,800 Direct +52.82% Acquired 200.1% (price as of 2026-08-19)
Nov. 11, 2022 ENTX P 50,000 $0.53 $26,500 56,800 Direct +735.29% Acquired 471.8% (price as of 2026-08-19)
Jan. 14, 2022 ENTX P 6,800 $2.79 $18,972 6,800 Direct — Acquired 8.6% (price as of 2026-08-19)
Dec. 27, 2021 NXGLW P 1,819 $5.49 $9,986 1,819 Direct — Acquired -99.7% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Aug. 7, 2026 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (500,000) $1.37 May 6, 2036 500,000 Acquired
Aug. 7, 2026 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (200,000) $2.81 Aug. 7, 2036 200,000 Acquired
July 16, 2025 ENTX Stock Option (Right to Buy) Ordinary Shares, par value NIS 0.0000769 per share (500,000) $2.28 April 28, 2035 500,000 Acquired
July 31, 2024 ENTX Stock Option (Right to Buy) Ordinary Shares, par value NIS 0.0000769 per share (500,000) $1.99 April 19, 2034 500,000 Acquired
Dec. 22, 2023 ENTX Warrants (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (23,952) — Dec. 22, 2028 23,952 Acquired
Sept. 13, 2023 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (350,000) $0.80 April 24, 2033 350,000 Acquired
Sept. 7, 2022 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (600,000) $1.40 July 15, 2032 600,000 Acquired
Sept. 7, 2022 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (500,000) $2.02 May 16, 2032 500,000 Acquired
Jan. 1, 2022 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (107,557) $2.82 Jan. 1, 2032 107,557 Acquired
Jan. 1, 2022 ENTX Stock Option (right to buy) Ordinary Shares, par value NIS 0.0000769 per share (35,852) $2.82 Jan. 1, 2032 35,852 Acquired
Dec. 27, 2021 NXGLW Warrant to Purchase Common Stock Common Stock (1,819) $5.50 Dec. 26, 2026 1,819 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 11, 2022 ENTX Stock Option (right to buy)→ Ordinary Shares, par value NIS 0.0000769 per share (33,638) 33,638 Direct
Sept. 15, 2021 NXGLW Options to Purchase Common Stock→ Common Stock (500,000) 500,000 Direct
June 29, 2021 CMPX Common Stock, $.0001 Par Value 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ENTX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2025 $490 — — — — — — $1,482
2024 $419 — — $538 — — $36 $1,149
2023 $338 — — — — — $80 $950

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.